Information about Biosensys
My details
*
*
*

Biosensys (SA)

BE 0871.249.941

Avenue des Etats-Unis 7, 6041 Charleroi

Company information

Status
Active

Enterprise number

BE0871.249.941

VAT liability
Yes
Established
17-01-2005
Last balance sheet year
2024
Company size
Medium-sized 0 FTE
Principal activity
Rental and operating of own or leased real estate
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Biosensys

2024 2023 2022 2021
Profit/Loss € -87,062 -43 % € -60,679 -43 % € -42,377 46 % € -78,955
Equity € 820,788 -10 % € 907,849 -6 % € 968,528 -4 % € 1,010,905
Gross margin € 1,909 -99 % € 199,504 84 % € 108,645 72 % € 63,211

Publications from Biosensys

Date Publication
22-07-2024 Capital, Shares (FR)
06-10-2023 Resignations, Appointments (FR)
29-08-2023 Capital, Shares - Resignations, Appointments (FR)
15-04-2021 Resignations, Appointments (FR)
01-07-2019 Resignations, Appointments (FR)

Frequently asked questions

What is the VAT number of Biosensys?
The VAT number of Biosensys is BE 0871.249.941.
Wat is the PEPPOL ID of Biosensys?
The PEPPOL ID of Biosensys is 0208:0871249941. Log in or start a free trial to see the full overview.
When was Biosensys founded?
Biosensys was founded on 17-01-2005.
What is the address of Biosensys?
The current registered office of Biosensys is located at Avenue des Etats-Unis 7, 6041 Charleroi.
When was the last time Biosensys filed their annual financial statements?
The most recent financial statements of Biosensys were filed on 14-12-2025.
How many employees does Biosensys have?
There are currently no employees working at Biosensys or no workforce information is available.
What is the annual turnover of Biosensys?
At the time of its most recent financial statements, Biosensys did not publish any turnover figures. Biosensys reported a gross margin of €1,909.30.

Sources